Algert Global’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.81M | Buy |
131,758
+63,074
| +92% | +$1.19M | 0.03% | 745 |
|
|
2026
Q1 | $1.2M | Buy |
68,684
+44,062
| +179% | +$874K | 0.02% | 827 |
|
|
2025
Q4 | $483K | Sell |
24,622
-52,240
| -68% | -$1.08M | 0.01% | 952 |
|
|
2025
Q3 | $2.12M | Buy |
76,862
+10,012
| +15% | +$308K | 0.04% | 673 |
|
|
2025
Q2 | $2.04M | Buy |
+66,850
| New | +$1.9M | 0.04% | 626 |
|
|
2023
Q1 | – | Sell |
-4,549
| Closed | -$242K | – | 1319 |
|
|
2022
Q4 | $242K | Sell |
4,549
-14,870
| -77% | -$806K | 0.01% | 973 |
|
|
2022
Q3 | $1.09M | Buy |
19,419
+4,293
| +28% | +$284K | 0.07% | 506 |
|
|
2022
Q2 | $1.09M | Sell |
15,126
-911
| -6% | -$67.8K | 0.08% | 428 |
|
|
2022
Q1 | $1.27M | Buy |
16,037
+9,511
| +146% | +$857K | 0.08% | 414 |
|
|
2021
Q4 | $660K | Sell |
6,526
-1,480
| -18% | -$148K | 0.08% | 435 |
|
|
2021
Q3 | $738K | Buy |
8,006
+3,619
| +82% | +$348K | 0.1% | 375 |
|
|
2021
Q2 | $449K | Sell |
4,387
-5,578
| -56% | -$560K | 0.15% | 198 |
|
|
2021
Q1 | $973K | Buy |
9,965
+3,306
| +50% | +$301K | 0.31% | 112 |
|
|
2020
Q4 | $513K | Buy |
+6,659
| New | +$515K | 0.15% | 221 |
|
|
2017
Q2 | – | Sell |
-21,843
| Closed | -$1.26M | – | 355 |
|
|
2017
Q1 | $1.26M | Buy |
21,843
+1,685
| +8% | +$101K | 0.34% | 126 |
|
|
2016
Q4 | $1.23M | Buy |
20,158
+4,240
| +27% | +$276K | 0.35% | 114 |
|
|
2016
Q3 | $1.1M | Buy |
15,918
+7,144
| +81% | +$471K | 0.32% | 125 |
|
|
2016
Q2 | $489K | Buy |
8,774
+82
| +0.9% | +$4.95K | 0.2% | 201 |
|
|
2016
Q1 | $528K | Sell |
8,692
-928
| -10% | -$54.6K | 0.2% | 188 |
|
|
2015
Q4 | $614K | Hold |
9,620
| – | – | 0.29% | 133 |
|
|
2015
Q3 | $645K | Hold |
9,620
| – | – | 0.36% | 99 |
|
|
2015
Q2 | $657K | Buy |
9,620
+2,020
| +27% | +$128K | 0.36% | 100 |
|
|
2015
Q1 | $422K | Hold |
7,600
| – | – | 0.23% | 168 |
|
|
2014
Q4 | $390K | Buy |
7,600
+680
| +10% | +$33.4K | 0.23% | 171 |
|
|
2014
Q3 | $255K | Sell |
6,920
-8,360
| -55% | -$302K | 0.19% | 208 |
|
|
2014
Q2 | $597K | Sell |
15,280
-35,520
| -70% | -$1.32M | 0.38% | 105 |
|
|
2014
Q1 | $1.91M | Sell |
50,800
-80
| -0.2% | -$2.79K | 0.76% | 33 |
|
|
2013
Q4 | $1.92M | Hold |
50,880
| – | – | 0.51% | 64 |
|
|
2013
Q3 | $2.21M | Hold |
50,880
| – | – | 0.63% | 42 |
|
|
2013
Q2 | $1.84M | Buy |
+50,880
| New | +$1.55M | 0.57% | 51 |
|
Other funds holding USNA
NCM
Algert Global's USNA Position: Q2 2026 in Review
Algert Global increased its Usana Health Sciences (USNA) stake by 92% in Q2 2026, buying an estimated $1.19M and bringing the position to 131,758 shares worth $2.81M. The position accounts for 0.03% of the portfolio, ranked #745.
Algert Global first reported a position in USNA in Q2 2013 and has held it in 30 quarters since. 138 funds tracked by Wall St. Rank hold USNA as of Q2 2026.
- Algert Global held 131,758 shares of Usana Health Sciences worth $2.81M as of Q2 2026.
- Algert Global bought 63,074 Usana Health Sciences shares in Q2 2026, an estimated $1.19M.
- Usana Health Sciences made up 0.03% of Algert Global's portfolio in Q2 2026, its #745 holding.
- Algert Global first reported a position in Usana Health Sciences in Q2 2013 and has held it in 30 quarters since.
- 138 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2026.
Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.